Aeluma is trading at $12.05, down -5.48%; no new company-specific announcement explaining the September 30 pre-market decline was identified.
- The latest company results were released September 16.
- A reported CEO stock sale was executed September 21 under a previously adopted Rule 10b5-1 plan, so it is not a clear overnight catalyst.
- Major indices are modestly higher in the supplied market context, which does not explain the opposite-direction move.